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to state "these results do show that both chloral hydrate and dichlorphenazone are unsuitable sedatives for patients on oral anticoagulants" is to draw a conclusion which is not very constructive and may be considered impractical.
Ideally Removal of Abnormal Protein SIR,-Dr. R. Powles and others (18 September, p. 664) indicate the undoubted value to some patients with paraproteinaemia of plasma exchange by means of a continuous flow blood cell separator. The procedure produces good clinical results associated with significant lowering of abnormal protein levels while the use of freeze dried plasma maintains normal or near normal immunoglobulin and clotting factor levels.
However, patients with paraproteinaemia often require repeated runs on the blood cell separator, and once the striking benefits of plasma exchange carried out in this way are fully realized the extremely limited facilities available in Britain will be overwhelmed.
The blood cell separator is an expensive machine and has usually been purchased in connexion with leukaemia research projects when its main uses are the provision of granulocytes (and perhaps platelets where these cannot be obtained elsewhere) from HL-A matched healthy donors for treating patients with marrow aplasia and the provision of blast cells from acute leukaemic patients for active immunotherapy and supporting investigations. I am aware of the existence of only tiree cell separators in Britain, and over any reasonable period of time a maximum of about five patients a week can be accommodated by a single team. It is thus important to assess the likely numbers of patients who could reasonably be treated by the method outlined by Dr. Powles and colleagues so that additional machines can be provided.
